DavidAD'AlessioMD

PubMed

• 122 citations
  Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
  J. Hans DeVries, Stephen C. Bain, Helena W. Rodbard, Jochen Seufert, David A. D'Alessio
  Diabetes Care. 2012-07-01
• 306 citations
  Central Control of Body Weight and Appetite
  Stephen C. Woods, David A. D'Alessio
  The Journal of Clinical Endocrinology and Metabolism. 2008-11-01
• 112 citations
  Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
  Juraj Koska, Michelle Sands, Camelia Burciu, Karen D'Souza, Kalyani Raravikar
  Diabetes. 2015-07-01

Journal Articles

• Acute administration of acyl, but not desacyl ghrelin, decreases blood pressure in healthy humans  
  Zhang CJ, Bidlingmaier M, Altaye M, Page LC, D'Alessio D, Tschop MH, Tong J, Eur J Endocrinol, 1/1/2017
• Disruption of Glucagon-Like Peptide 1 Signaling in Sim1 Neurons Reduces Physiological and Behavioral Reactivity to Acute and Chronic Stress  
  Ghosal S, Packard AE, Mahbod P, McKlveen JM, Seeley RJ, Myers B, Ulrich-Lai Y, Smith EP, D'Alessio DA, Herman JP, J Neurosci, 1/1/2017
• The incretin effect in obese adolescents with and without type 2 diabetes: Impaired or intact?  
  Aulinger BA, Vahl TP, Prigeon RL, D'Alessio DA, Elder DA, Am J Physiol Endocrinol Metab, 1/1/2016
• Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1  
  Tong J, Davis HW, Gastaldelli A, D'Alessio D, J Clin Endocrinol Metab, 1/1/2016
• Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation  
  Alzaman NS, Dawson-Hughes B, Nelson J, D'Alessio D, Pittas AG, Am J Clin Nutr, 1/1/2016
• Baseline factors associated with glycaemic response to treatment with weekly dulaglutide in patients with type 2 diabetes  
  Wysham C, Guerci B, D'Alessio D, Jia N, Botros FT, Diabetes Obes Metab, 1/1/2016
• Is GLP-1 a hormone: Whether and When?  
  D'Alessio D, J Diabetes Investig, 1/1/2016
• Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth  
  Shah AS, D'Alessio D, Ford-Adams ME, Desai AP, Inge TH, Diabetes Care, 1/1/2016
• Bariatric/metabolic surgery for diabetes: Incorporating a powerful treatment into standard care  
  Wolfe BM, D'Alessio DA, Obesity, 1/1/2016
• Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe  
  Salehi M, D'Alessio DA, Surg Obes Relat Dis, 1/1/2016
• Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes  
  D'Alessio D, Häring HU, Charbonnel B, de Pablos-Velasco P, Candelas C, Dain MP, Vincent M, Pilorget V, Yki-Jarvinen H, Diabetes Obes Metab, 1/1/2015
• Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes  
  Elder DA, Hornung LN, Herbers PM, Prigeon R, Woo JG, D'Alessio DA, J Pediatr, 1/1/2015
• Insulin detemir is transported from blood to cerebrospinal fluid and has prolonged central anorectic action relative to NPH insulin  
  Begg D, May A, Mul JD, Liu M, D'Alessio DA, Seeley RJ, Woods SC, Diabetes, 1/1/2015
• Exenatide protects against glucose and lipid-induced endothelial dysfunction: Evidence for direct vasodilation effect of GLP-1 receptor agonists in humans  
  Koska J, Sands M, Burciu C, D'Souza K, Raravikar K, Liu J, Truran S, Franco DA, Schwartz EA, Schwenke DC, D'Alessio D, Migrino RQ, Reaven PD, Diabetes, 1/1/2015
• Beta-cell sensitivity to GLP-1 in healthy humans is variable and proportional to insulin sensitivity  
  Aulinger BA, Vahl TP, Wilson-Perez HE, Prigeon RL, D'Alessio DA, J Clin Endocrinol Metab, 1/1/2015
• Diet-Induced Obese Mice Retain Endogenous Leptin Action  
  Ottaway N, Mahbod P, Rivero B, Norman LA, Gertler A, D'Alessio DA, Perez-Tilve D, Cell Metab, 1/1/2015
• Ghrelin  
  Muller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, Batterham RL, Benoit SC, Bowers CY, Broglio F, Casanueva FF, D'Alessio D, Depoortere I, Geliebte..., Mol Metab, 1/1/2015
• Mouse handling limits the impact of stress on metabolic endpoints  
  Ghosal S, Nunley A, Mahbod P, Lewis AG, Smith EP, Tong J, D'Alessio DA, Herman JP, Physiol Behav, 1/1/2015
• Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion  
  Salehi M, Woods SC, D'Alessio DA, Obesity, 1/1/2015
• Insulin Sensitivity and beta-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents  
  Inge TH, Prigeon RL, Elder DA, Jenkins TM, Cohen RM, Xanthakos SA, Benoit SC, Dolan LM, Daniels SR, D'Alessio DA, J Pediatr, 1/1/2015
• Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes ...  
  Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D'Alessio DA, Am J Clin Nutr, 1/1/2015
• Physiology of Proglucagon Peptides: The role of glucagon and GLP-1 in health and disease  
  Sandoval D and D’Alessio DA, Phys Rev, 1/1/2015
• Ghrelin and hypothalamic development: too little and too much of a good thing  
  Tong J, D'Alessio D, J Clin Invest, 1/1/2015
• Controversial Issues: When the drugs don't work, can surgery provide a different outcome for diabetic adolescents?  
  Beamish AJ, D'Alessio DA, Inge TH, Surg Obes Relat Dis, 1/1/2015
• An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes  
  Rosario W, D'Alessio D, Diabetes, 1/1/2015
• Join now to see all

Books/Book Chapters

• Textbook of Diabetes 
  Chapter: Glucagon in Islet and Metabolic Regulation 
  Page 103.0 - 113.0Sandoval D, Tong J, D’Alessio DEditors: Holt, Cockram, Flyvbjerg Goldstein.JohnWiley and Sons, Ltd, Chichester, West Sussex, UKEdition 5th,2017
• Therapy for Diabetes Mellitus and Related Disorders 
  Chapter: GLP-1 based drugs 
  Diab D, D’Alessio DAEditors: G Umpierrez.Alexandria, VAEdition 6th,2014
• Manual of Obstetrics 
  Chapter: Endocrine Disorders: Thyroid, Parathyroid, Adrenal, and Pituitary Disease 
  Valent AM, D’Alessio DAEditors: AT Evans.Philadelphia, PAEdition 8th,2014
• Obesity 
  Chapter: Environmental factors influencing obesity 
  Brehm, B. and D’Alessio, DEditors: M. Weickert.2014
• Goodman and Gilman’s The Pharmacologic Basis of Therapeutics 
  Chapter: Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia 
  Page 1237. - 1274.Powers AC, D’Alessio DAEditors: Brunton, Chabner, Knollman.New York, NYEdition 12th,2013
• Diabetes: Translating Research into Practice 
  Chapter: The incretin effect: Regulation of insulin secretion and glucose tolerance by GI hormones 
  D’Alessio DA, Aulinger BA, Salehi MEditors: CJ Greenbaum and CH Harrison.New York, NY2008
• Ellenberg and Rifkin’s Diabetes Mellitus 
  Chapter: Incretins: Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like peptide 1 
  Page 85.0 - 96.0D’Alessio DAEditors: Baron, Porte Jr. and Sherwin.New York, NY2002
• The insulinotropic hormone Glucagon-like peptide 1 
  Chapter: The regulation of islet hormone secretion by GLP-1 in humans 
  Page 132.0 - 141.0D’Alessio DA, Ensinck JWEditors: Fehman, Goke and Goke.Basel1996
• Frontiers in Diabetes Research, Lessons from animal diabetes 
  Chapter: Consequences of human IAPP expression in transgenic mice 
  Verchere CB, D'Alessio DA, Kahn SEEditors: Shafrir and Renold.London1994
• Join now to see all